Assessment of the Changes in Cortical and Medullary Renal Blood Flow During Exercise in Healthy Subjects Using Contrast Enhanced Ultrasound
研究概览
详细说明
This study requires a screening day and two visits on separate days to the Clinical Research Unit (CRU). Three visits total.
Screening Visit:
- The subjects will undergo detailed history and physical examination.
- The inclusion and exclusion criteria will be reviewed.
- The details of the study procedures, potential risks and benefits will be reviewed with each subject and all potential questions will be answered.
- Subjects' understating of all details of the study components will be ascertained and they will be asked to sign the informed consent form.
- A copy of the signed informed consent will be placed in study file and another copy will be provided to each subject.
- The study visit day will be scheduled within 2 weeks of the screening day.
- All subjects will be asked to arrive on their first study day after an overnight fast. They will be instructed to avoid caffeine and exercise for 24 hours.
Study Day #1 The subjects will arrive in the CRU in the morning. Subjects' understanding of all study related procedures will be assessed and all remaining questions will be answered. The following sequence of procedures will be followed for all enrolled subjects.
- Physical exam including vital signs (Blood Pressure, Heart Rate, Weight, Height, Respiration Rate, Temperature)
Urine pregnancy test for women of child bearing age. If positive, subjects will be excluded.
Determination of peak oxygen consumption
Subjects will complete a continuous VO2 peak bicycle ergometer protocol.
- Each subject will start peddling on a stationary bike
- The initial power output (PO) will be set at 20 watts
- The power output will be increased by 15 watts every 2-minutes until volitional exhaustion.
- Metabolic data will be collected during the protocol using standard open-circuit spirometric techniques (Viasys Vmax Encore, Yorba Linda, CA)
- Heart rate was assessed electrocardiographically.
- VO2 peak will be chosen as the highest VO2 attained during the exercise protocol
On Day 2 of testing
- Check Vitals (BP, HR, Wt., RR, Temp.)
- Insert peripheral IV line Baseline renal blood flow measurement using contrast enhanced ultrasonography
- The Definity vial will be placed at room temperature before being used. It will be activated after shaking the vial using Vialmax® for 45 seconds. It will be used immediately after activation.
- 0.4 ml of Definity will be mixed in 10 ml of preservative free saline.
- Infusion of Definity into a peripheral vein will be started at 2 ml/min and titrated for optimal image quality using a minipump (not to exceed 10 ml/min at any time).
- Baseline contrast ultrasound imaging of right kidney will be performed with low mechanical index (MI) of 0.2.
- 4 - 5 ultrasound impulses with high MI of 1.0 and duration of 1 second will be used to destruct the microbubbles in the kidney tissue
- Ultrasound imaging of the kidney with low MI (0.2) will continue immediately after each impulse for several seconds.
- Infusion of Definity will stop at this point.
- Vital signs will be monitored every 15 minutes and continuous pulse oximetry will be performed during Definity administration.
- Vital signs and pulse oximetry will be monitored every 15 minutes until 30 minutes after discontinuation of Definity.
A urine dipstick will be performed by the study team 30 minutes after completion of Definity infusion if a sample is available.
Constant load Exercise protocol
- Subjects will complete 30 minutes of continuous cycling at the power output associated with 85% of VO2peak from the continuous bicycle ergometer protocol. Metabolic data will be collected as described above.
- Once metabolic parameter are reached, exercise will be stopped and subject will be asked to lie down on the bed Renal Blood flow measurement following exercise using contrast enhanced ultrasonography
- Immediately after completion of exercise protocol, steps 5 - 12 under day 2 procedures will be repeated.
- The study procedures will end at this point.
研究类型
注册 (预期的)
阶段
- 阶段2
- 阶段1
联系人和位置
学习地点
-
-
Virginia
-
Charlottesville、Virginia、美国、22908
- 招聘中
- University of Virginia
-
接触:
- Sharon F Johnson, BA
- 电话号码:434-982-3198
- 邮箱:sfj8n@virginia.edu
-
接触:
- Kambiz Kalantarinia, MD
- 电话号码:4349823198
- 邮箱:KK6C@hscmail.mcc.virginia.edu
-
首席研究员:
- Kambiz Kalantarinia, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Healthy Adult - 18 to 50 years old
- All ethnicity and genders
Exclusion Criteria:
- Pregnancy or lactation
- Active infection
- Hypertension
- Chronic Medication Use except Multi Vitamin Use and Birth Control Medications
- Known history of a right to left intra-cardiac shunt
- Known history of pulmonary hypertension, including porto-pulmonary hypertension
- History of allergies to Definity®
- History of Liver or Kidney Transplant
- Patient on hemodialysis
- Has received iodinated contrast within 72 hours of admission to study
学习计划
研究是如何设计的?
设计细节
- 主要用途:诊断
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Healthy Test Subjects
We will be using the drug Definity that is an approved medication for cardiac contrast enhanced ultrasound to measure the changes in kidney blood flow with exercise in healthy subjects.
|
其他名称:
During kidney ultrasound, Definity microbubbles will be injected into the vein to see how blood flows through the kidneys
其他名称:
This done before and after exercise with the help of Definity to see changes in kidney blood flow
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in renal blood flow in exercise as assessed by CEUS
大体时间:Before and immediately after exercise
|
Total, cortical and medullary kidney blood flow will be measured using contrast-enhanced ultrasonography
|
Before and immediately after exercise
|
合作者和调查者
调查人员
- 首席研究员:Kambiz Kalantarinia, MD、University of Virginia, Department of Nephrology
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.